Navidea Biopharmaceuticals Inc (Navidea Biopharmaceuticals Inc (NAVB)) has risen Tuesday morning, with the stock rising 10.32% in pre-market trading to 3.1.
NAVB's short-term technical score of 26 indicates that the stock has traded less bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 72 out of 146 industries, the stock ranks higher than 30% of stocks.
Navidea Biopharmaceuticals Inc has risen 30.70% over the past month, closing at $2.37 on January 12. During this period of time, the stock fell as low as $2.18 and as high as $3.09. NAVB has an average analyst recommendation of Strong Buy. The company has an average price target of $7.50.
Navidea Biopharmaceuticals Inc has a Long-Term Technical rank of 11. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 89% of the market scoring higher. In the Biotechnology industry which is number 59 by this metric, NAVB ranks better than 15% of stocks.
Important Dates for Investors in NAVB:
-Navidea Biopharmaceuticals Inc is set to release earnings on 3/10/2021. During their last earnings release the company posted EPS of $-0.51. -We do not have a set dividend date for Navidea Biopharmaceuticals Inc at this time. Click Here to get the full Stock Score Report on Navidea Biopharmaceuticals Inc (NAVB) Stock.
